Nov 2, 2026 · Science & Research Daily Digest
A Nov 2, 2026 roundup of science, space, biomedicine, and climate-research headlines, with summaries, links, and brief commentary.
I. Space & Deep Exploration
1. NASA’s ESCAPADE twins set Nov. 7/9 powered Earth flybys en route to Mars (deep space)
Summary:
NASA’s Goddard Space Flight Center reported on Nov. 2 that the Escape and Plasma Acceleration and Dynamics Explorers (ESCAPADE) will each execute a powered Earth flyby—an Oberth maneuver combining gravity assist with an ~9-minute engine burn—around 5 a.m. EST on Nov. 7 and 6 a.m. EST on Nov. 9. The burns should raise speed from about 6.3 to about 6.7 miles per second (more than 1,000 mph), starting a ~10-month cruise with Mars arrivals planned for Sept. 7 and 9, 2027. NASA says no prior Mars-bound craft has successfully flown this powered-flyby path; at Mars, ESCAPADE aims to be the first multi-spacecraft formation mission studying solar-wind interactions and atmospheric loss. Launched in November 2025 when Earth and Mars were on opposite sides of the Sun, the pair loitered near Earth–Sun L2 before returning for the assist once the planets realigned.
Links:
Commentary:
Turning a missed launch window into an engineered gravity assist is clever; the science payoff is still the dual-probe view of solar-wind–driven atmospheric escape.
2. Hubble GLOW census: nearby dwarfs keep only ~4%–25% of stellar oxygen (astrophysics)
Summary:
NASA announced on Nov. 2 that the Galaxies Losing Oxygen via Winds (GLOW) project, led by Kristen Wingfield McQuinn (Rutgers / STScI), used Hubble-resolved stellar populations plus Spitzer, VLA, and ATCA data to budget oxygen in 37 nearby dwarf galaxies (D < ~6 Mpc; stellar masses ~10⁶·⁵–10⁹·⁵ solar masses). The study, published the same day in The Astrophysical Journal, finds the galaxies retain only about 4%–25% of nucleosynthetic oxygen (mean ~11%), almost entirely in gas; supernova-driven winds appear more effective at ejecting oxygen than models predict. Halo O VI can account for only a fraction of the missing oxygen, so whether most remains in the circumgalactic medium or has escaped to the intergalactic medium is still open; denser environments and proximity to massive neighbors increase scatter in retention.
Links:
- NASA Science — Hubble Uncovers Missing Oxygen in Nearby Dwarf Galaxies
- ApJ — GLOW. II. A Census of Oxygen in Low-mass Galaxies
Commentary:
Matching the mass–metallicity relation is not the same as getting dwarf metal retention right—observations are now quantifying how much oxygen simulations over-retain.
3. ISS Expedition 75 preps final roll-out solar array spacewalk (on-orbit engineering)
Summary:
NASA’s Nov. 2 station blog says Expedition 75 continues preparations for Thursday’s second—and final—power-upgrade spacewalk in the series. CSA’s Joshua Kutryk and NASA’s Anil Menon plan to start about 8:10 a.m. EST on a roughly seven-hour EVA to install the eighth and last roll-out solar array (iROSA) on the starboard truss, raising generating capacity from about 160 kW to about 215 kW (~30%). Kutryk, Menon, Jessica Watkins, and Luke Delaney rehearsed Canadarm2 procedures and held conferences with EVA and robotics teams; concurrent work included Bio-Monitor cardiorespiratory monitoring, biofabricated vascular tissue care, and portable DNA sequencer checks.
Links:
Commentary:
Once the last iROSA is locked in, ISS power expansion shifts from construction to harvesting the capacity gain.
II. Biomedicine & Health
4. FDA accepts uniQure Huntington’s gene-therapy BLA with Priority Review (gene therapy)
Summary:
uniQure said on Nov. 2 that FDA accepted the Biologics License Application for ifezuntirgene inilparvovec (AMT-130) for Huntington’s disease under the Accelerated Approval pathway with Priority Review and a PDUFA date of May 1, 2027; the agency tentatively plans an advisory committee meeting. The one-time therapy delivers a huntingtin-silencing miRNA to the striatum via MRI-guided stereotactic surgery. The filing rests on 36-month Phase I/II data versus an Enroll-HD external control; uniQure says it aligned with FDA on a ~200-patient confirmatory trial (2:1 versus standard of care; Total Functional Capacity at 36 months) with U.S. screening expected by year-end 2026. Approval would, the company argues, yield the first disease-modifying Huntington’s treatment, though weaker four-year readouts leave advisory scrutiny as a key uncertainty.
Links:
- uniQure — FDA Acceptance and Priority Review of AMT-130 BLA
- Fierce Biotech — FDA grants uniQure priority review
Commentary:
Priority Review puts a date on the calendar; the advisory committee’s view of external controls and later follow-up attenuation will decide whether the milestone sticks.
5. Weill Cornell: selective TNKS2 blockade hits WNT where tumors lost TNKS1/8p (oncology)
Summary:
A Weill Cornell Medicine team led by Lukas Dow reported on Nov. 2 in Nature Chemical Biology that many cancers delete tankyrase 1 (TNKS1) via chromosome 8p loss and become dependent on largely redundant TNKS2 for WNT signaling. Structure-guided design yielded a first-in-class inhibitor ~30-fold selective for TNKS2 over TNKS1 that suppressed WNT and growth in TNKS1-deficient cells and organoids without apparent effects on TNKS1-intact healthy cells. Hyperactive WNT is nearly universal in colorectal cancer and common in breast and other solid tumors; dual tankyrase inhibitors have hit dose-limiting on-target toxicity in early trials. The work remains preclinical; the lab aims to improve drug-like properties before fuller IND-enabling studies.
Links:
- Cornell Chronicle — New strategy may target common cancer driver
- Nature Chemical Biology — Selective TNKS2 inhibitor for tumor-restricted WNT suppression
Commentary:
Turning a common chromosomal deletion into synthetic lethality is a rare clean path around decades of WNT-drug toxicity.
6. Yale: NELF pausing and MLLT1/3 recruitment unlock somatic hypermutation (immunity)
Summary:
Yale School of Medicine coverage on Nov. 2 highlighted a Nature paper from David Schatz’s lab detailing how B-cell somatic hypermutation (SHM) is gated. Using engineered RASH-1C cells for rapid mutation readouts, Lizhen Wu and colleagues found that negative elongation factor (NELF) hitchhikes with RNA polymerase II into antibody loci and pauses transcription, exposing single-stranded DNA for activation-induced deaminase (AID); MLLT1 and MLLT3 recruit AID to the correct region, and losing either abolishes SHM. Mutation rates there can exceed other genomic regions by about a million-fold; the work converts a decades-old speculation about dedicated SHM facilitators into concrete molecular players.
Links:
- Medical Xpress / Yale — How the immune system gets better at detecting pathogens
- Nature — Transcription pause and elongation regulators mediate somatic hypermutation
Commentary:
Knowing when the DNA “door” opens and who escorts AID is foundational for both vaccine responses and antibody engineering.
7. Nature Neuroscience highlight: human AD/CBD tau strains template-seed faithful mouse folds (neurodegeneration)
Summary:
A Nov. 2 Nature Neuroscience research highlight covers work by Lövestam, Shimozawa, Tarutani and colleagues (MRC LMB / Tokyo Metropolitan Institute of Medical Science) in Nature: tau filaments extracted from Alzheimer’s disease or corticobasal degeneration brains, injected into wild-type mice, seed endogenous mouse tau into amyloid filaments whose atomic structures match the human seeds. AD seeds mainly yielded paired helical filaments restricted to neurons; CBD seeds produced CBD-fold filaments involving neurons and glia, recapitulating disease-specific cellular tropism. Human seeds disappeared within about a week while mouse pathology accumulated over months, supplying long-sought structural proof of prion-like templated tau propagation; which step preserves fold fidelity remains open.
Links:
- Nature Neuroscience — Misfolded tau propagates via templated seeding
- Nature — Prion-like transmission of human tau strains in the mouse brain
Commentary:
Strain identity that survives cross-species copying gives anti-seed strategies a harder structural bull’s-eye.
III. Climate, Energy & Environment
8. CityUHK infrared-transparent aerogel WITA adds up to ~5.2°C extra daytime cooling (passive cooling)
Summary:
City University of Hong Kong announced on Nov. 2 that Edwin Tso’s team, with Xi’an Jiaotong University collaborators, published a white infrared-transparent aerogel (WITA) in Energy & Environmental Science. Built on ultra-high-molecular-weight PE via one-step solvent exchange, WITA reaches up to ~94.5% atmospheric-window transmittance and ~96.6% solar reflectance, spatially decoupling solar reflection from thermal insulation when layered on subambient daytime radiative cooling (SDRC) coatings. Hong Kong field tests showed up to ~5.2°C extra subambient cooling versus bare SDRC; Abu Dhabi hot-arid trials likewise favored WITA-covered SDRC. Building-energy modeling for a four-storey apartment in Abu Dhabi estimated ~14.6 GJ annual savings for an SDRC roof versus a conventional roof, with WITA boosting those SDRC savings by about 55%; optical performance held after accelerated UV aging equivalent to ~two years outdoors in Hong Kong.
Links:
Commentary:
A few extra degrees without electricity matter most when they show up on a roof’s annual energy ledger.
9. Zhejiang U. team: metallomesogen grain-boundary fix yields 31.62% certified perovskite/Si tandem (PV)
Summary:
Yong Wang, Deren Yang, Xuegong Yu and colleagues at Zhejiang University reported on Nov. 2 in Nature Energy a Pb-based metallomesogen that heals grain-boundary distortion caused by oversized FA doping in Cs(FA)PbI₃ wide-bandgap front cells. The mesophase spreads along boundaries, relieving shear strain and suppressing defects. Perovskite/silicon tandems using a ~1.66 eV absorber with a Br-containing boundary modifier reached 32.08% champion efficiency (certified 31.62%), retained ~95% of initial performance after ~3,000 h of maximum-power-point tracking, and ~93% after ~1,500 h at 85% RH / 85°C. The work targets the tandem commercialization bottleneck of pairing efficiency with durability; a related Chinese provisional patent was filed.
Links:
Commentary:
Beyond the certified headline, the 3,000-hour MPP and damp-heat retention numbers are what decide whether tandems leave the lab.
IV. Basic Research & Cross-Cutting Tech
10. MIT: ultra-flexible ligands create spontaneous valency in nanoparticle superlattices (materials)
Summary:
MIT’s Robert Macfarlane and collaborators reported on Nov. 2 in Nature Materials (and MIT News) that isotropic nanoparticles with sufficiently deformable, electrostatically tipped ligands can reconfigure during assembly to generate effective valency without pre-patterned particle anisotropy. Greater ligand deformability lowers coordination number, packing density, and symmetry, enabling low-coordination lattices hard-sphere packing would not predict; particle size and chain length tune bond counts and previously unseen crystal structures. The approach aims at scalable “designer materials” for photonics, catalysis, medicine, and more.
Links:
- MIT News — Flexible new route to designer materials from nanoparticles
- Nature Materials — Breaking symmetry via spontaneous valency
Commentary:
Twenty years of “ligands must be rigid” dogma flips—flexibility itself becomes a programmable structural knob.
11. CETC network institute: Beidou micro-base stations clear underground nav acceptance at <0.2 m static accuracy (PNT)
Summary:
Xinhua / People’s Daily reported on Nov. 2 that a national R&D project on high-precision positioning, navigation, and control in large underground spaces, led by China Electronics Technology Group’s Network Communication Research Institute national key lab, passed Ministry of Science and Technology acceptance. The “Xingyuan” Beidou micro-base-station system radiates Beidou signals underground for seamless above-/below-ground navigation; Xiong’an tests cited static personnel accuracy better than 0.2 m and sub-meter guidance for high-speed unmanned vehicles. The team also proposed an HNav-UWB navigation-enhanced ultra-wideband standard and developed the “Tanjie 100” pulse positioning chip (ranging better than 10 cm; angle better than 3°), claiming ~28% greater coverage, ~6% better ranging, and >65% higher single-station capacity versus common international standards. Deployments span parking garages, utility corridors, and coal-mine personnel/vehicle dispatch.
Links:
Commentary:
The PNT “second half” where satellites cannot reach is what makes parking, corridors, and mine robots actually scalable.
Today's Summary
- NASA set ESCAPADE’s unprecedented dual powered Earth flybys toward Mars; Hubble’s GLOW census quantifies dwarf-galaxy oxygen loss.
- uniQure’s Huntington gene therapy entered Priority Review; TNKS2-selective WNT blockade and SHM molecular switches opened fresh oncology and immunology levers.
- CityUHK’s WITA aerogel and Zhejiang’s perovskite/Si tandem delivered same-day progress on passive cooling and high-efficiency PV.
- MIT flexible-ligand assembly and China’s underground Beidou micro-base stations advanced materials design and engineered PNT together.
Daily Framing:
A day when deep-space trajectory engineering and hard biomedical structure/genetics evidence moved in parallel—from Mars pathfinding to tau-strain fidelity and TNKS2 synthetic lethality.
This digest is compiled from real-time search results and is for reference only.